55
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Vismodegib and orbital excision for treating locally advanced basal cell carcinoma

, &
Pages 177-179 | Published online: 31 Jul 2018

References

  • AllaliJD’HermiesFRenardGBasal cell carcinomas of the eyelidsOphthalmologica20052192577115802929
  • SunMTWuAFigueiraEHuilgolSSelvaDManagement of periorbital basal cell carcinoma with orbital invasionFuture Oncol201511223003301026437207
  • TyersAGOrbital exenteration for invasive skin tumoursEye200620101165117017019414
  • Ackuaku-DogbeEMBiritwumRBBriamahZIPsycho-social challenges of patients following orbital exenterationEast Afr Med J2012891238538926852450
  • SekulicAMigdenMRLewisKPivotal ERIVANCE basal cell carcinoma (BCC) study: 12-month update of efficacy and safety of vismodegib in advanced BCCJ Am Acad Dermatol201572610211026.e825981002
  • JuhaszMLMarmurESSystematic review of vismodegib toxicity profile in the treatment of advanced basal cell carcinomas compared to other systemic therapies in dermatologyJ Drugs Dermatol201413672973324918565
  • WongKYFifeKLearJTPriceRDDurraniAJVismodegib for locally advanced periocular and orbital basal cell carcinoma: a review of 15 consecutive casesPlast Reconstr Surg Glob Open201757e142428831360
  • GillHSMoscatoEEChangALSoonSSilkissRZVismodegib for periocular and orbital basal cell carcinomaJAMA Ophthalmol2013131121591159424136169